Clinical Trials Logo

Infection clinical trials

View clinical trials related to Infection.

Filter by:

NCT ID: NCT00156546 Active, not recruiting - Clinical trials for Urinary Tract Infections

Evaluation of the Effectiveness of Antibiotic Prophylaxis in Children With a Previous Urinary Tract Infection

Start date: May 2000
Phase: Phase 4
Study type: Interventional

Our hypothesis is that long-term antimicrobial prophylaxis does not reduce the recurrence of infection and the risk of appearance of kidney scars in children with a documented previous upper UTI.

NCT ID: NCT00156377 Completed - Clinical trials for Staphylococcal Infections

Prophylaxis With Intranasal Mupirocin for Prevention of S. Aureus Infections

Start date: November 2002
Phase: Phase 4
Study type: Interventional

In order to evaluate the effect of eliminating nasal carriage by mupirocin prophylaxis on subsequent Staphylococcus aureus infection, a prospective randomized trial was performed particularly including patients with predisposing risk factors for S. aureus infections.

NCT ID: NCT00155623 Completed - H. Pylori Infection Clinical Trials

Establish Epidemiologic Data of H. Pylori Infection in Children and Adolescents-Using C13-UBT

Start date: February 2001
Phase: N/A
Study type: Observational

The aims of this prospective study are: (1) to prospectively investigate the "true" prevalence rate, the acquisition and spontaneous clearance of H. pylori infection year by year in the population whose ages between seven and fifteen. (2) to explore the risk factors of transmission of H. pylori infection in Taiwan. (This information may be use as the guide for conduction of the national policy of public health and disease prevention.)

NCT ID: NCT00150852 Recruiting - Wound Infection Clinical Trials

Prevention of Gastrostomy-Related Wound Infection by Vancomycin in Carriers of Methicillin-Resistant Staphylococcus Aureus.

Start date: September 2004
Phase: Phase 2
Study type: Interventional

The aim of this study is to determine whether vancomycin with cefazoline is superior to vancomycin with placebo in preventing gastrostomy-related wound infection in carriers of methicillin-resistant staphylococcus aureus (MRSA).

NCT ID: NCT00150332 Completed - Clinical trials for Infections, Nosocomial

Linezolid for the Treatment of Infections Caused by Methicillin Resistant Staphylococcus Aureus in Japan

Start date: January 2003
Phase: Phase 3
Study type: Interventional

Use of linezolid in patients with methicillin-resistant Staphylococcus aureus infections in Japan

NCT ID: NCT00149890 Completed - Infection Clinical Trials

Efficacy and Safety of Basiliximab, Cyclosporine/Cyclosporine Microemulsion, and Steroids in Pediatric de Novo Liver Transplant Recipients Avoiding Intraoperative Steroids

Start date: March 2004
Phase: Phase 3
Study type: Interventional

Systemic infection is still a major concern in young children with liver transplantation. The approach of this study is to reduce the risk of systemic infections by avoiding intraoperative steroids (another class of immunosuppressive drugs) given in combination with basiliximab, cyclosporine and steroids in pediatric de novo liver transplant recipients. The treatment is compared to the same treatment regimen including intraoperative steroids with respect to rejection episodes.

NCT ID: NCT00149084 Recruiting - Gastritis Clinical Trials

Tailored Treatment of H. Pylori Infection Based Polymorphisms of CYP2C19 and 23S rRNA of H. Pylori

Start date: April 2003
Phase: Phase 3
Study type: Interventional

The eradication rate of the standard H. pylori eradication therapy (such as the triple therapy with a proton pump inhibitor [PPI], amoxicillin and clarithromycin) depends on bacterial susceptibility to clarithromycin and genotypes of CYP2C19 in patients. The investigators intend to investigate whether the tailored therapy based on the two above-mentioned factors increases the cure rate of the initial eradication therapy.

NCT ID: NCT00144287 Completed - HIV Infections Clinical Trials

Safety Study of Tipranavir Co-administered With Low-dose Ritonavir (TPV/r) in Patients With Advanced HIV-1 Infection and Limited Treatment Options

Start date: May 2004
Phase: Phase 3
Study type: Interventional

This study evaluated the safety and tolerability of tipranavir to improve treatment options for HIV type 1-infected patients who have been previously treated and whose treatment is no longer effective.

NCT ID: NCT00143312 Completed - Clinical trials for Prophylaxis Of Invasive Fungal Infections

Voriconazole for Secondary Prophylaxis of Invasive Fungal Infections in Patients With Allogeneic Stem Cell Transplants

VOSIFI
Start date: February 2005
Phase: Phase 4
Study type: Interventional

To prevent recurrence of invasive fungal infection in patients with allogeneic stem cell transplants

NCT ID: NCT00140335 Completed - Clinical trials for Communicable Diseases

Evaluation of a Handwashing Promotion Program in Chinese Elementary Schools

Start date: December 2004
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine the effects of a commercial hand washing promotion program on hygiene knowledge, attitudes, and practices, and on health outcomes such as reported infectious illnesses and school absences.